Literature DB >> 1891986

Immunopathogenesis of multiple sclerosis.

H Wekerle1.   

Abstract

The immunopathogenesis of MS is discussed in the light of data recently obtained in Experimental Autoimmune Encephalomyelitis (EAE), a myelin specific experimental autoimmune disease reflecting the first, inflammatory phase of MS plaque generation. EAE is caused by CD4+ T cells specific for defined myelin protein, like MBP and PLP. In rats and mice there is a marked dominance of the autoantigenic peptide epitopes on the one hand, and the T cell receptor V regions on the other. During T cell mediated EAE, clonotypically counterregulatory CD8+ T cells are induced, which specifically neutralize the encephalitogenic T clones.

Entities:  

Mesh:

Year:  1991        PMID: 1891986

Source DB:  PubMed          Journal:  Acta Neurol (Napoli)        ISSN: 0001-6276


  8 in total

1.  Murine whole-organ immune cell populations revealed by multi-epitope-ligand cartography.

Authors:  Jenny Eckhardt; Christian Ostalecki; Katarzyna Kuczera; Gerold Schuler; Ansgar J Pommer; Matthias Lechmann
Journal:  J Histochem Cytochem       Date:  2012-11-16       Impact factor: 2.479

2.  Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitis.

Authors:  Harley Y Tse; Jinzhu Li; Xiaoqing Zhao; Fei Chen; Peggy P Ho; Michael K Shaw
Journal:  Curr Trends Immunol       Date:  2012

3.  Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.

Authors:  Nitin J Karandikar; Michael P Crawford; Xiao Yan; Robert B Ratts; Jason M Brenchley; David R Ambrozak; Amy E Lovett-Racke; Elliot M Frohman; Peter Stastny; Daniel C Douek; Richard A Koup; Michael K Racke
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

4.  Clonal composition of neuroantigen-specific CD8+ and CD4+ T-cells in multiple sclerosis.

Authors:  Brian W Biegler; Shirley X Yan; Sterling B Ortega; Deepani K Tennakoon; Michael K Racke; Nitin J Karandikar
Journal:  J Neuroimmunol       Date:  2011-03-11       Impact factor: 3.478

Review 5.  Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.

Authors:  Danielle M Turley; Stephen D Miller
Journal:  Results Probl Cell Differ       Date:  2010

6.  CD154 blockade results in transient reduction in Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  Laurence M Howard; Katherine L Neville; Lia M Haynes; Mauro C Dal Canto; Stephen D Miller
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 7.  Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease.

Authors:  Emily M L Chastain; Stephen D Miller
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

8.  CTLA-4: a negative regulator of autoimmune disease.

Authors:  N J Karandikar; C L Vanderlugt; T L Walunas; S D Miller; J A Bluestone
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.